Filing Flows › TriSalus Life Sciences (TLSI) › Recalls, complaints & regulation

TriSalus Life Sciences (TLSI): clinical trials

TriSalus Life Sciences (TLSI) beyond its filings: 1 active clinical trial.

TriSalus Life Sciences' latest quarter

TriSalus Life Sciences, Q2 2026: revenue $11.4M (+2% year over year), operating margin -86.0%, net loss $9.2M, operating cash flow −$10.1M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does TriSalus Life Sciences have?

1 active study on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.